Data as of Aug 27
| +0.20 / +0.37%|
The 12 analysts offering 12-month price forecasts for Hospira Inc have a median target of 55.00, with a high estimate of 65.00 and a low estimate of 41.00. The median estimate represents a +1.40% increase from the last price of 54.24.
The current consensus among 17 polled investment analysts is to Hold stock in Hospira Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.